This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Advanced Accelerator Applications SA
Drug Names(s): 68Ga-PSMA-SR6
68Ga-PSMA-SR6 is in development as a companion diagnostic for prostate cancer through novel molecular nuclear medicine techniques.
Advanced Accelerator Applications plans to radiolabel PSMA-SR6 to develop a 177Lu-PSMA-SR6 to treat and monitor prostate cancer and a 68Ga-PSMA-SR6, which will help to diagnose and stage disease.
This is a companion diagnostic to be used with:
Additional information available to subscribers only: